Faculty profile

Neil Cashman

ResearcherUBC James Hogg Research CentreUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Neil Cashman

Researcher

UBC James Hogg Research Centre

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
6 publications in the last five years, latest in 2024.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 14 research grants (9 CIHR, 3 NSERC, 2 SSHRC), most recently in 2018.
Supervisor on 3 trainee awards (3 CIHR), most recently in 2010.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Amyotrophic Lateral Sclerosis Neurodegeneration Protein Misfolding Autophagy Prion-Like Enterovirus Prion Sod1

Latest papers

Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA)
Journal of Alzheimer's Disease · 2024
A Systematic Review of the Genetics and Pathology of Psychosis in Frontotemporal Dementia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2024
Diagnosis of manganism and manganese neurotoxicity: A workshop report.
Medicine international · 2024

All 23 publications

Latest funding

A comprehensive approach to halt chronic wasting disease transmission
NSERC · 2021 · Co-investigator
$1,472,160
Role of enteroviral infection in amyotrophic lateral sclerosis
CIHR · 2018 · Principal investigator
$1,002,150
A Defined Abeta Oligomer Epitope: Theranostic Applications
CIHR · 2015 · Nominated PI
$419,232

All 19 grants and awards

23 publications.

Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA)

Chertkow H, Phillips N, Rockwood K, Anderson N, Andrew MK, Bartha R, Beaudoin C, Bélanger N, Bellec P, Belleville S

Journal of Alzheimer's Disease20249 citations

DOI: 10.1177/13872877241290990

A Systematic Review of the Genetics and Pathology of Psychosis in Frontotemporal Dementia.

Chatterjee A, Hirsch-Reinshagen V, Scott I, Cashman N, Hsiung GR

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques2024

DOI: 10.1017/cjn.2023.248 PMID: 37385628

Diagnosis of manganism and manganese neurotoxicity: A workshop report.

Mattison DR, Momoli F, Alyanak C, Aschner M, Baker M, Cashman N, Dydak U, Farhat N, Guilarte TR, Karyakina N, Ramoju S, Shilnikova N, Taba P, Krewski D

Medicine international2024

DOI: 10.3892/mi.2024.135 PMID: 38410758

Should we screen aging physicians for cognitive decline?

Shilnikova N, Momoli F, Taher MK, Go J, McDowell I, Cashman N, Terrell R, Iscan Insel E, Beach J, Kain N, Krewski D

Aging & mental health2024

DOI: 10.1080/13607863.2023.2252371 PMID: 37691440

Primary lateral sclerosis.

Marzoughi S, Pfeffer G, Cashman N

Handbook of clinical neurology2023Senior author

DOI: 10.1016/b978-0-323-98817-9.00021-1 PMID: 37620095

A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG.

Li FF, Liu A, Gibbs E, Tanunliong G, Marquez AC, Gantt S, Frykman H, Krajden M, Morshed M, Prystajecky NA, Cashman N, Sekirov I, Jassem AN

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology2022

DOI: 10.1016/j.jcv.2021.105050 PMID: 34883405

Tardive neurotoxicity of anticholinergic drugs: A review.

Marzoughi S, Banerjee A, Jutzeler CR, Prado MAM, Rosner J, Cragg JJ, Cashman N

Journal of neurochemistry2021Senior author

DOI: 10.1111/jnc.15244 PMID: 33222198

Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson's disease models.

Jin JW, Fan X, Del Cid-Pellitero E, Liu XX, Zhou L, Dai C, Gibbs E, He W, Li H, Wu X, Hill A, Leavitt BR, Cashman N, Liu L, Lu J, Durcan TM, Dong Z, Fon EA, Wang YT

Communications biology2021

DOI: 10.1038/s42003-021-01746-6 PMID: 33608634

A Longitudinal Study of the Neurologic Safety of Acute Baclofen Use After Spinal Cord Injury.

Cragg JJ, Tong B, Jutzeler CR, Warner FM, Cashman N, Geisler F, Kramer JLK

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2019

DOI: 10.1007/s13311-019-00713-8 PMID: 30725362

Rapid myelin water imaging for the assessment of cervical spinal cord myelin damage.

Dvorak AV, Ljungberg E, Vavasour IM, Liu H, Johnson P, Rauscher A, Kramer JLK, Tam R, Li DKB, Laule C, Barlow L, Briemberg H, MacKay AL, Traboulsee A, Kozlowski P, Cashman N, Kolind SH

NeuroImage. Clinical2019

DOI: 10.1016/j.nicl.2019.101896 PMID: 31276928

A comprehensive approach to halt chronic wasting disease transmission

Co-investigatorNSERC2021Alliance Grants

Principal investigators: Gilch, Sabine S

$1,472,160

Role of enteroviral infection in amyotrophic lateral sclerosis

Principal investigatorCIHR2018Project Grant

Principal investigators: Luo, Honglin; Cashman, Neil R

Keywords: Amyotrophic Lateral Sclerosis; Autophagy; Enterovirus; Neurodegeneration; Prion; Protein Misfolding; Sod1; Tdp-43

$1,002,150

A Defined Abeta Oligomer Epitope: Theranostic Applications

Nominated PICIHR2015Operating Grant: Industry-partnered Collaborative Research

Principal investigators: Cashman, Neil R

Keywords: Abeta Oligomers; Active Immunization; Alzheimer Disease; Biomarkers; Commercialization; Diagnosis; Knowledge Translation; Oligomer-Specific Antibodies; Passive Immunization; Therapeutic

$419,232

Pathobiological mechanisms of misfolded wild-type Cu/Zn superoxide dismutase: A common pathway in amyotrophic lateral sclerosis

Nominated PICIHR2014Operating Grant - Priority Announcement: ALS Canada Research Fund

Principal investigators: Cashman, Neil R

Keywords: Amyotrophic Lateral Sclerosis; Autophagy; Neurodegeneration; Neurotoxicity; Prion-Like; Propagated Protein Misfolding; Proteasome

A defined cyclic peptide epitope specific to Abeta oligomers: Active and passive vaccination in mouse models of Alzheimer's disease

Nominated PICIHR2012Proof of Principle Program - Phase II

Principal investigators: Cashman, Neil R

Keywords: Alzheimer'S Disease; Amyloid Beta (Abeta); Conformation-Specific Antibodies; Immunotherapies; Oligomers; Vaccines

$300,000

Misfolding of Cu/Zn superoxide dismutase by pathological FUS and TDP43: relevance to amyotrophic lateral sclerosis

Nominated PICIHR2012Operating Grant - Priority Announcement: Neuromuscular Research

Principal investigators: Cashman, Neil R

Keywords: Amyotrophic Lateral Sclerosis; Neurodegeneration; Prion-Like; Protein Misfolding; Rna Processing; Template Directed Misfolding

$89,576

Molecular Origins of Protein Misfolding and Neurodegenerative Disease

Co-investigatorCIHR2012Planning Grants - Priority Announcement: Aging

Principal investigators: Plotkin, Steven S

Keywords: Alzheimer'S Disease; Amyloids; Amyotrophic Lateral Sclerosis; Cytotoxicity; Misfolding And Aggregation; Neurodegeneration; Oligomers; Parkinson'S Disease; Prions; Proteostasis

$25,000

Novel anti-inflammatory treatment for Amyotrophic Lateral Sclerosis

Principal investigatorCIHR2011Proof of Principle Program Phase I - Drug Development

Principal investigators: Hancock, Robert Ernest W; Cashman, Neil R

Keywords: Amyotropic Lateral Sclerosis; Animal Models; Anti-Inflammatory Treatment; Chemokines; Cytokines; Immunomodulation; Innate Defence Regulator Peptides; Microglial Cells; Motor Neoron Disease; Neuroinflammation

$160,000

CANADA RESEARCH CHAIRHOLDER - TITULAIRE DE CHAIRE DE RECHER DU CANADA

Nominated PICIHR2011Canada Research Chairs - CIHR Funded - Tier 1

Principal investigators: Cashman, Neil R

Keywords: Chairs

$1,400,000

PRION 2011: The New World

Nominated PICIHR2010Planning Grants - Priority Announcement: Infection and Immunity

Principal investigators: Cashman, Neil R

Keywords: Highly Qualified Personnel; International; Knowledge Exchange; Networking; Prion Research

$25,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Neil Cashman

Research

Latest papers

Latest funding

Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA)

A Systematic Review of the Genetics and Pathology of Psychosis in Frontotemporal Dementia.

Diagnosis of manganism and manganese neurotoxicity: A workshop report.

Should we screen aging physicians for cognitive decline?

Primary lateral sclerosis.

A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG.

Tardive neurotoxicity of anticholinergic drugs: A review.

Development of an &#x3b1;-synuclein knockdown peptide and evaluation of its efficacy in Parkinson's disease models.

A Longitudinal Study of the Neurologic Safety of Acute Baclofen Use After Spinal Cord Injury.

Rapid myelin water imaging for the assessment of cervical spinal cord myelin damage.

A comprehensive approach to halt chronic wasting disease transmission

Frequent collaborators

Daniel Krewski

Ian Mackenzie

Philip Griebel

Andrew Potter

Michelle Wong

Franco Momoli

Serge Gauthier

Elizabeth Finger

Andrew Lim

Howard Feldman

Marc Fabian

Mark Rapoport

Mel Krajden

Sandra Black

Eric Smith

Gillian Einstein

Colleen Maxwell

Howard Chertkow

Kenneth Rockwood

Heather Stewart

Robert Bartha

Cheryl Wellington

Nicole Anderson

Margaret Fahnestock

Bojana Stefanovic

Alex Mihailidis

Edward Fon

Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson's disease models.